Log in to save to my catalogue

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid c...

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10394138

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers

About this item

Full title

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2023-08, Vol.114 (8), p.3385-3395

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Comprehensive genomic profiling (CGP) tests have been covered by public insurance in Japan for patients with advanced solid tumors who have completed or are completing standard treatments or do not have them. Therefore, genotype‐matched drug candidates are often unapproved or off‐label, and improving clinical trial access is critical, involving the...

Alternative Titles

Full title

Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10394138

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10394138

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15837

How to access this item